Compass Therapeutics Inc. (CMPX)
undefined
undefined%
At close: undefined
1.46
0.34%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 1.89M 1.90M 1.62M 2.40M 2.12M 1.92M
Gross Profit -1.89M -1.90M -1.62M -2.40M -2.12M -1.92M
Operating Income -50.36M -41.66M -81.88M -27.81M -34.05M -38.31M
Interest Income - 2.36M 29.00K 88.00K 743.00K 663.00K
Pretax Income -42.49M -39.23M -82.18M -29.47M -34.65M -38.18M
Net Income -42.49M -36.80M -82.55M -29.50M -34.74M -38.29M
Selling & General & Admin 11.05M 11.66M 10.93M 12.91M 11.60M 11.22M
Research & Development 37.42M 30.00M 20.34M 14.90M 22.45M 27.09M
Other Expenses - - 50.62M - - -
Operating Expenses 48.47M 41.66M 31.26M 27.81M 34.05M 38.31M
Interest Expense - 2.36M 370.00K 908.00K 1.23M 767.00K
Selling & Marketing Expenses 11.04M - - - - -
Cost & Expenses 50.36M 41.66M 31.26M 27.81M 34.05M 38.31M
Income Tax - -2.43M 370.00K 32.00K 91.00K 103.00K
Shares Outstanding (Basic) 127.03M 105.19M 62.87M 30.78M 52.11M 52.11M
Shares Outstanding (Diluted) 127.03M 105.19M 62.87M 30.78M 52.11M 52.11M
EPS (Basic) -0.33 -0.35 -1.31 -0.96 -0.67 -0.73
EPS (Diluted) -0.33 -0.35 -1.31 -0.96 -0.67 -0.73
EBITDA -48.47M -37.39M -29.61M -25.32M -31.19M -35.73M
Depreciation & Amortization 1.89M 1.90M 1.62M 2.40M 2.12M 1.92M